{"schema_version":"secwatch.filing_event.v1","accession":"0001159036-25-000049","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2025-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.905075+00:00","generated_at":"2026-05-16T22:55:52.749558+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Halozyme prices $1.3B convertible notes offering; to repurchase ~$1.02B of existing 2027/2028 notes","bullets":["Priced $650M of 0% convertible notes due 2031 and $650M of 0.875% notes due 2032; initial purchasers have 13-day option for additional $200M.","Initial conversion price of ~$87.20/share, a 27.5% premium over the $68.39 closing price on Nov. 6, 2025.","Net proceeds of ~$1.274B ($1.47B if option exercised); ~$1.019B to repurchase outstanding 0.25% 2027 and 1.00% 2028 notes.","Entered into capped call transactions with cap price of $136.78/share to reduce potential dilution upon conversion.","Expected to close offering on November 12, 2025; remainder of proceeds for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001159036-25-000049","json":"https://secwatch.observer/filing/0001159036-25-000049.json","markdown":"https://secwatch.observer/filing/0001159036-25-000049.md","text":"https://secwatch.observer/filing/0001159036-25-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000049/0001159036-25-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000049/halo-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:55:52.749558+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}